Back
Roivant Sciences 10K Form
Sell
34
ROIV
Roivant Sciences
Last Price:
11.15
Seasonality Move:
19.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ROIV News And Ratings
See the #1 stock for the next 7 days that we like better than ROIV
ROIV Financial Statistics
Sales & Book Value
| Annual Sales: | $124.8M |
|---|---|
| Cash Flow: | $-193.79M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.35 |
| Price / Book: | 1.58 |
Profitability
| EPS (TTM): | 5.56000 |
|---|---|
| Net Income (TTM): | $4.74B |
| Gross Margin: | $109.24M |
| Return on Equity: | 109.69% |
| Return on Assets: | 93.84% |
Roivant Sciences Earnings Forecast
Key Roivant Sciences Financial Ratios
- The Gross Profit Margin over the past 4 years for ROIV is 87.53%.
- The Selling, General & Administrative Expenses for ROIV have been equal to 550.86% of Gross Profit Margin.
- The Research & Development expenses have been 402.05% of Revenue.
- The Interest Expense is 0.80% of Operating Income.
- The Net Earning history of ROIV is 3,484.86% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 1 years.
Roivant Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ROIV |
| Website: | roivant.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 27.91 |
| Quick Ratio: | 27.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.23 |
|---|---|
| Forward P/E Ratio: | 0 |
ROIV Technical Analysis vs Fundamental Analysis
Sell
34
Roivant Sciences (ROIV)
is a Sell
Is Roivant Sciences a Buy or a Sell?
-
Roivant Sciences stock is rated a Sell
The current Roivant Sciences [ROIV] share price is $11.20. The Score for ROIV is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.